Pathways Balancing Basal Mucin and CFTR-Mediated Fluid Secretion in (...) - Kenichi Okuda, MD, PhD

Cystic Fibrosis Research Institute
Cystic Fibrosis Research Institute
11
0
Published 2024-01-17
Dr. Kenichi Okuda, a Research Associate at Marsico Lung Institute at University of North Carolina at Chapel Hill, presents results from CFRI-funded research on pathways maintaining basal mucin and CFTR-mediated fluid secretion in the human distal airway. He argues that airway cells are a therapeutic target for molecular therapy for CFTR function restoration. This presentation was part of CFRI's 36th National CF Education Conference.

CFRI's 36th National CF Education Conference was sponsored by Viatris, Vertex Pharmaceuticals, Gilead Sciences, Chiesi USA, AbbVie, Genentech, and the Boomer Esiason Foundation.
All Comments (1)